Randall Pellish to Gastrointestinal Agents
This is a "connection" page, showing publications Randall Pellish has written about Gastrointestinal Agents.
Connection Strength
1.045
-
Cappuccio JM, Mehta N, Pellish R. Inpatient Infliximab Biosimilar Cost-Savings: Cost Analysis of Inpatient Treatment with Originator Infliximab (Remicade?) versus Biosimilar Infliximab (Renflexis?) for Acute Severe Ulcerative Colitis. Dig Dis. 2024; 42(5):496-502.
Score: 0.917
-
Stein BN, Pellish RS, Thompson KD, Baptista V, Siegel CA. Using Therapeutic Drug Monitoring to Identify Variable Infliximab Metabolism in an Individual Patient With Ulcerative Colitis. J Clin Gastroenterol. 2016 Jan; 50(1):66-8.
Score: 0.128